Effect of vasoactive intestinal peptide (VIP) on propranolol-induced bronchoconstriction
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 82 (4) , 617-621
- https://doi.org/10.1016/0091-6749(88)90973-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of infused vasoactive intestinal peptide on airway function in normal subjects.Thorax, 1986
- Inhibitory effects of clonidine on bronchospasm induced in guinea-pigs by vagal stimulation or antigen challengeEuropean Journal of Pharmacology, 1986
- The Effect of Inhaled Vasoactive Intestinal Peptide on Bronchial Reactivity to Histamine in HumansAmerican Review of Respiratory Disease, 1984
- Control of neurotransmission by prostaglandins in canine trachealis smooth muscleJournal of Applied Physiology, 1984
- Characterization and Localization of Vasoactive Intestinal Peptide Receptors in the Rat LungEndocrinology, 1984
- VASOACTIVE INTESTINAL PEPTIDE CAUSES BRONCHODILATATION AND PROTECTS AGAINST HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ASTHMATIC SUBJECTSThe Lancet, 1983
- Control of human airway smooth muscle: in vitro studiesJournal of Applied Physiology, 1982
- Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranesBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Vasoactive Intestinal Peptide: A Possible Transmitter of Nonadrenergic Relaxation of Guinea Pig AirwaysScience, 1980
- Autonomic innervation of the lung musculature of a toad (Bufo marinus)Comparative and General Pharmacology, 1971